Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

25 August 2021: Clinical Research

“Obesity Paradox” in Acute Respiratory Distress Syndrome Among Patients Undergoing Cardiac Surgery: A Retrospective Study

Yan Liu 1ABCDEFG , Man Song 1BCDF , Lixue Huang 2BCDF , Guangfa Zhu 13ACG*

DOI: 10.12659/MSM.931808

Med Sci Monit 2021; 27:e931808

Supplementary Table 3 Baseline characteristics of patients with acute respiratory distress syndrome (n=202).

BMI<18.5≥18.5, <25≥25, <30≥30P value
N (%)14 (6.93%)108 (53.47%)62 (30.69%)18 (8.91%)
Age, years51.79±16.1657.07±14.1962.39±10.9856.83±13.900.019
Smoking index300.00 (200.00–550.00)500.00 (400.00–800.00)550.00 (300.00–800.00)800.00 (600.00–1050.00)0.354
EF value before surgery, %39.21±31.0352.04±23.4948.34±26.0152.06±25.200.296
Hemoglobin level before surgery, g/l111.21±16.68120.33±23.74131.61±21.79129.00±23.640.002
Albumin level before surgery, g/l41.00±3.5737.81±9.4336.97±7.3036.00±10.230.365
APACHE II value17.79±4.9819.43±5.2820.52±6.2320.00±7.100.378
Duration of surgery, hours5.48±1.686.53±2.776.25±2.906.26±(2.890.586
Blood loss, ml700.00 (400.00–800.00)1000.00 (700.00–1300.00)1000.00 (725.00–1500.00)750.00 (500.00–1425.00)0.285
Transfusion of red blood cells, ml400.00 (300.00–575.00)800.00 (400.00–1000.00)800.00 (410.00–1181.50)700.00 (400.00–900.00)0.310
Transfusion of plasma cells, ml400.00 (0.00–475.00)400.00 (0.00–400.00)200.00 (0.00–400.00)0.00 (0.00–150.00)0.186
EF value after surgery, %30.50±23.9849.31±17.2450.32±16.4254.78±22.05
Duration of incubation time, hours41.00 (0.00–144.00)115.50 (45.50–263.85)115.10 (48.67–394.73)360.00 (192.00–483.25)0.001
Gender, %0.010
 Male12 (85.71%)78 (72.22%)34 (54.84%)8 (44.44%)
 Female2 (14.29%)30 (27.78%)28 (45.16%)10 (55.56%)
History of cardiac surgery, %0.003
 No14 (100.00%)88 (81.48%)61 (98.39%)17 (94.44%)
 Yes0 (0.00%)20 (18.52%)1 (1.61%)1 (5.56%)
History of hypertension, %
 No13 (92.86%)60 (55.56%)22 (35.48%)0 (0.00%)
 Yes1 (7.14%)48 (44.44%)40 (64.52%)18 (100.00%)
History of diabetes, %0.315
 No13 (92.86%)85 (78.70%)46 (74.19%)12 (66.67%)
 Yes1 (7.14%)23 (21.30%)16 (25.81%)6 (33.33%)
History of AMI, %0.013
 No12 (85.71%)87 (80.56%)38 (61.29%)16 (88.89%)
 Yes2 (14.29%)21 (19.44%)24 (38.71%)2 (11.11%)
Emergency surgery, %0.090
 No14 (100.00%)95 (87.96%)50 (80.65%)13 (72.22%)
 Yes0 (0.00%)13 (12.04%)12 (19.35%)5 (27.78%)
Type of surgery, %0.019
 Isolated valvular surgery or isolated CABG surgery8 (57.14%)50 (46.30%)37 (59.68%)9 (50.00%)
 Valvular combined with CABG surgery3 (21.43%)20 (18.52%)4 (6.45%)2 (11.11%)
 Aortic surgery0 (0.00%)15 (13.89%)16 (25.81%)6 (33.33%)
 Others3 (21.43%)23 (21.30%)5 (8.06%)1 (5.56%)
Infection after surgery0.745
 No9 (64.29%)67 (62.04%)36 (58.06%)13 (72.22%)
 Yes5 (35.71%)41 (37.96%)26 (41.94%)5 (27.78%)
IABP after surgery
 No11 (78.57%)81 (75.00%)51 (82.26%)15 (83.33%)0.676
 Yes3 (21.43%)27 (25.00%)11 (17.74%)3 (16.67%)
ECMO after surgery0.352
 No12 (85.71%)95 (87.96%)54 (87.10%)13 (72.22%)
 Yes2 (14.29%)13 (12.04%)8 (12.90%)5 (27.78%)
CRRT after surgery0.920
 No9 (64.29%)71 (65.74%)43 (69.35%)13 (72.22%)
 Yes5 (35.71%)37 (34.26%)19 (30.65%)5 (27.78%)
Tracheotomy after surgery0.498
 No12 (85.71%)73 (67.59%)40 (64.52%)12 (66.67%)
 Yes2 (14.29%)35 (32.41%)22 (35.48%)6 (33.33%)
Second intubation after surgery0.009
 No2 (14.29%)41 (37.96%)35 (56.45%)10 (55.56%)
 Yes12 (85.71%)67 (62.04%)27 (43.55%)8 (44.44%)
Survive0.009
 No0 (0.00%)33 (30.56%)28 (45.16%)7 (38.89%)
 Yes14 (100.00%)75 (69.44%)34 (54.84%)11 (61.11%)
EF – ejection fraction; COPD – chronic obstructive pulmonary disease; IBW – ideal body weight; AMI – acute myocardial infarction; CABG – coronary artery bypass grafting; APACHE – acute physiology and chronic health evaluation; ARDS – acute respiratory distress syndrome; IABP – intra-aortic balloon pump; ECMO – extracorporeal membrane oxygenation therapy; CRRT – continuous renal replacement therapy

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750